Investor Alert

New York Markets Open in:

Intercept Pharmaceuticals Inc.

NAS: ICPT

GO
/marketstate/country/us

After Hours

/zigman2/quotes/202434567/composite

$

13.83

Change

0.00 0.00%

Volume

Volume 68,986

Mar 27, 2023, 5:54 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202434567/composite

Previous close

$ 13.46

$ 13.83

Change

+0.37 +2.75%

Day low

Day high

$13.26

$13.89

Open
Open: 13.46

52 week low

52 week high

$10.81

$21.86

Open

Market cap

$560.88M

Average volume

760,787

P/E ratio

2.12

Rev. per Employee

$837,859

EPS

6.54

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/icpt

MarketWatch News on ICPT

  1. Two Years Later, Intercept Takes Another Run at NASH

    11:13 a.m. July 8, 2022

    - Barron's Online

  2. Intercept set to meet with FDA in July about NASH drug

    8:30 a.m. June 6, 2022

    - Jaimy Lee

  3. Intercept Pharmaceuticals stock price target cut to $31 from $43 at Canaccord Genuity

    9:22 a.m. Aug. 3, 2021

    - Tomi Kilgore

  4. The FDA's Biogen Decision Will Cause Waves Across Biotech

    9:20 p.m. June 1, 2021

    - Barron's Online

  5. Intercept Pharmaceuticals downgraded to neutral from buy at B. Riley

    7:23 a.m. May 26, 2021

    - Tomi Kilgore

  6. Intercept Pharmaceuticals stock price target cut to $74 from $97 at B. Riley FBR

    8:28 a.m. Nov. 20, 2020

    - Tomi Kilgore

  7. Intercept Pharmaceuticals upgraded to outperform from market perform at Raymond James

    8:47 a.m. Nov. 10, 2020

    - Tomi Kilgore

  8. Intercept shares gain after it announces layoffs

    8:19 a.m. Sept. 2, 2020

    - Jaimy Lee

  9. A Top Contender Drops Out of Race for a NASH Drug

    11:15 a.m. July 23, 2020

    - Barron's Online

  10. Biogen Submits Troubled Alzheimer’s Drug for FDA Approval

    12:07 p.m. July 8, 2020

    - Barron's Online

  11. Analysts Are Downgrading Intercept Pharmaceuticals. Here’s Why.

    11:53 a.m. June 30, 2020

    - Barron's Online

  12. Intercept Pharmaceuticals downgraded to market perform at BMO Capital

    9:07 a.m. June 30, 2020

    - Tomi Kilgore

  13. Intercept Pharmaceuticals stock price target cut to $97 from $158 at B. Riley FBR

    7:53 a.m. June 30, 2020

    - Tomi Kilgore

  14. Intercept Pharmaceuticals stock price target cut to $50 from $89 at SVB Leerink

    6:11 a.m. June 30, 2020

    - Tomi Kilgore

  15. Intercept Shares Tumble on NASH Disappointment

    4:05 p.m. June 29, 2020

    - Barron's Online

  16. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/icpt

Other News on ICPT

  1. 10-K: INTERCEPT PHARMACEUTICALS, INC.

    5:35 p.m. March 2, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  2. Intercept updates Phase 3 data for the NASH candidate

    10:26 a.m. Nov. 7, 2022

    - Seeking Alpha

  3. Intercept updates Phase 3 data for the NASH candidate

    10:22 a.m. Nov. 7, 2022

    - Seeking Alpha

  4. Intercept updates Phase 3 data for the NASH candidate

    10:22 a.m. Nov. 7, 2022

    - Seeking Alpha

  5. Intercept updates Phase 3 data for the NASH candidate

    10:22 a.m. Nov. 7, 2022

    - Seeking Alpha

  6. Intercept Pharmaceuticals: Trying Times

    12:30 a.m. Nov. 4, 2022

    - Seeking Alpha

  7. 10-Q: INTERCEPT PHARMACEUTICALS, INC.

    4:05 p.m. Nov. 1, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  8. MNSO and CLEU among mid-day movers

    1:40 p.m. Nov. 1, 2022

    - Seeking Alpha

  9. Notable earnings before Tuesday's open

    11:21 a.m. Oct. 31, 2022

    - Seeking Alpha

  10. Akero: Putting Together The Pieces They Let Us See

    6:51 p.m. Oct. 25, 2022

    - Seeking Alpha

  11. Loading more headlines...
/news/pressrelease/company/us/icpt

Press Releases on ICPT

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.